Introduction:Basic information about CAS 3225-26-1|4-benzoyloxy-tempo, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | 4-benzoyloxy-tempo |
|---|
| CAS Number | 3225-26-1 | Molecular Weight | 276.351 |
|---|
| Density | / | Boiling Point | / |
|---|
| Molecular Formula | C16H22NO3 | Melting Point | 99-101 °C(lit.) |
|---|
| MSDS | ChineseUSA | Flash Point | / |
|---|
Names
| Name | (1-λ1-oxidanyl-2,2,6,6-tetramethylpiperidin-4-yl) benzoate |
|---|
| Synonym | More Synonyms |
|---|
Chemical & Physical Properties
| Melting Point | 99-101 °C(lit.) |
|---|
| Molecular Formula | C16H22NO3 |
|---|
| Molecular Weight | 276.351 |
|---|
| Exact Mass | 276.159973 |
|---|
| PSA | 29.54000 |
|---|
| LogP | 3.14840 |
|---|
| InChIKey | MJEDTBDGYVATPI-UHFFFAOYSA-N |
|---|
| SMILES | CC1(C)CC(OC(=O)c2ccccc2)CC(C)(C)N1[O] |
|---|
| Stability | Stable. Incompatible with strong oxidizing agents. |
|---|
Safety Information
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|
| Risk Phrases | 36/37/38 |
|---|
| Safety Phrases | S22-S24/25 |
|---|
| RIDADR | NONH for all modes of transport |
|---|
| WGK Germany | 3 |
|---|
Articles5
More Articles
| Mechanistic analysis of PLGA/HPMC-based in-situ forming implants for periodontitis treatment. Eur. J. Pharm. Biopharm. 94 , 273-83, (2015) In-situ forming implant formulations based on poly(lactic-co-glycolic acid) (PLGA), acetyltributyl citrate (ATBC), minocycline HCl, N-methyl pyrrolidone (NMP) and optionally hydroxypropyl methylcellul... | |
| In-situ forming composite implants for periodontitis treatment: How the formulation determines system performance. Int. J. Pharm. 486 , 38-51, (2015) Periodontitis is the primary cause of tooth loss in adults and a very wide-spread disease. Recently, composite implants, based on a drug release rate controlling polymer and an adhesive polymer, have ... | |
J. Org. Chem. 55 , 462, (1990)
| |
Synonyms
| 4-benzoyloxy-2,6-tetramethylpiperidine-N-oxyl |
| 4-Benzoyloxy-TEMPO Free Radical |
| 4-Hydroxy-TEMPO benzoate,free radical |
| 4-benzoyloxy-2,2,6,6-tetramethylpiperidine-1-oxy |
| 4-Hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl benzoate |
| 4-BzO-TEMPO |
| 4-Benzoyloxy-2,2,6,6-tetramethylpiperidine 1-Oxyl Free Radical |
| [4-(Benzoyloxy)-2,2,6,6-tetramethyl-1-piperidinyl]oxidanyl |
| 1-Piperidinyloxy, 4-(benzoyloxy)-2,2,6,6-tetramethyl- |
| 4-PhCO2-TEMPO |
| 4-benzoyloxy-2,2,6,6-tetramethylpiperidine-1-oxyl |
| 4-Hydroxy-2,2,6,6-tetramethylpiperidine 1-Oxyl Benzoate Free Radical |
| [4-(Benzoyloxy)-2,2,6,6-tetramethylpiperidin-1-yl]oxidanyl |
| MFCD00075563 |
| 1-oxyl-2,2,6,6-tetramethlpiperidin-4-yl benzoate |
| 4-Benzoyloxy-TEMPO |
| 4-Hydroxy-TEMPO-benzoate |